Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its integrated drug creation platform comprises AI models aimed at designing better antibody therapeutics, including against hard-to-drug targets, as well as improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Absci Corporation

Analysts are intrested in these 5 stocks: ( ($NU) ), ( ($AVGO) ), ( ($UNH) ), ( ($ABSI) ) and ( ($TMC) ). Here is a breakdown of their recent


Nu, Broadcom, UNH, AbSci, TMC Trending With Analysts

AbSci ( ($ABSI) ) just unveiled an announcement. On June 4, 2026, Absci Corporation held its Annual Meeting of Stockholders, with 155,447,428 commo...

Absci Stockholders Approve Directors and Auditor at Meeting

Analysts are intrested in these 5 stocks: ( ($ABSI) ), ( ($SFIX) ), ( ($TNEYF) ), ( ($SNOW) ) and ( ($VMC) ). Here is a breakdown of their recent


Absci, Stitch Fix, Tamarack, Snowflake, Vulcan Trending With Analysts

Low‑priced stocks do not always mean low potential. Several under-$10 names are drawing fresh attention from Wall Street analysts thanks to rising ...

3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbSci (ABSI), Black Diamond Therapeutics (BDTX) and ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

In a report released yesterday, from Guggenheim reiterated a Buy rating on AbSci, with a price target of $10.00. In a report released today, H.C. W...

Guggenheim Remains a Buy on AbSci (ABSI)

Absci Corp. (($ABSI)) has held its Q1 earnings call. Read on for the main highlights of the call. Absci’s latest earnings call struck a cautiously ...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABSI	$6.65	+3.91%	440.87K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABSI	$6.65	+3.9%	440.87K
3
4
5
6

ABSI

ABSI

Dividend Overview

Get Absci Corporation Data in Excel

Get Absci Corporation Data in Excel